Dexmedetomidine infusion to facilitate opioid detoxification and withdrawal in a patient with chronic opioid abuse

Indian Journal of Palliative Care

Volumn 17, Issue 3, 2011, Pages 251-254

  Upadhyay, Surjya Prasad ^a   Mallick, Piyush Narayan ^a   Elmatite, Waleed Mohamed ^a   Jagia, Manish ^a   Taqi, Salah ^a  

^a AL JAHRA HOSPITAL   (Kuwait)

Author keywords

Dexmedetomedine; Facilitate; Opioid dependence; Substance abuse; Withdrawal symptoms

Indexed keywords

EID: 84856617768     PISSN: 09731075     EISSN: 19983735     Source Type: Journal    
DOI: 10.4103/0973-1075.92353     Document Type: Article

References (27)

1. Maccioli GA. Dexmedetomidine to facilitate drug withdrawal. Anesthesiology 2003;98:575-7.
2. O'Connor PG, Kosten TR, Stine SM. Management of opioid intoxication and withdrawal. In: Graham AW, Schultz TK, Mayo-Smith MF, et al, editor. Principles of addiction medicine. 3rd ed. Chevy Chase (MD): American Society of Addiction Medicine; 2003. p. 651-68.
3. Jaffe JH. Drug addiction and drug abuse. In: Gilman AG, Rall TW, Nies AS, Taylor P editors. Goodman and Gilman's the pharmacological basis of therapeutics. 8th ed. New York: Pergamon Press; 1990. p. 522-73.
4. Deighan CJ, Wong KM, Mclaughlin KJ, Harden P. Rhabdomyolysis and acute renal failure resulting from alcohol and drug abuse. QJM 2000;93: 29-33. (Pubitemid 30058014)
5. Kumar R, West DM, Jingree M, Laurance AS. Unusual consequences of heroin overdose: rhabdomyolysis, acute renal failure, paraplegia and hypercalcemia. Br J Anaesth 1999;83:496-8. (Pubitemid 29412715)
6. Wilson KC, Saukkonen JJ. Acute respiratory failure from abused substances. J Intensive Care Med 2004;19:183-93. (Pubitemid 44544699)
7. Ridgway ZA, Pountney AJ. Acute respiratory distress syndrome induced by oral methadone managed with non-invasive ventilation. Emerg Med J 2007;24:681. (Pubitemid 47343071)
8. Jenkins DH. Substance abuse and withdrawal in the intensive care unit: Contemporary issues. Surg Clin North Am 2000;80:1033-53. (Pubitemid 30396987)
9. Tobias JD. Tolerance, withdrawal, and physical dependency after long-term sedation and analgesia of children in the pediatric intensive care unit. Crit Care Med 2000;28:2122-32. (Pubitemid 30428787)
10. Littler C, Scobie SD, Shelly MP. Withdrawal of sedation after long term ventilation on the intensive care unit. Clin Intensive Care 1995;6:83-5.
11. Belgrade M, Hall S. Dexmedetomidine infusion for the management of opioid induced hyperalgesia. Pain Med 2010;11:1819-26.
12. Finkel JC, Elrefai A. The use of dexmedetomidine to facilitate opioid and benzodiazepine detoxification in an infant. Anesth Analg 2004;98:1658-9, table of contents. (Pubitemid 38668910)
13. Rahman RA, Azmi MH, Ishak NH, Manap NA, Zain JM. The use of dexmedetomidine for refractory agitation in substance abuse patient. Crit Care Shock 2010;13:59-60.
14. Multz AS. Prolonged dexmedetomidine infusion as an adjunct in treating sedation-induced withdrawal. Anesth Analg 2003;96:1054-5, table of contents. (Pubitemid 36359042)
15. Shafer A. Complications of sedation with midazolam in the intensive care unit and a comparison with other sedative regimens. Crit Care Med 1998;26:947-56. (Pubitemid 28211408)
16. Ghignone M, Quintin L, Duke PC, Kehler CH, Calvillo O. Effects of clonidine on narcotic requirements and hemodynamic response during induction of fentanyl anesthesia and endotracheal intubation. Anesthesiology 1986;64:36-42. (Pubitemid 16186770)
17. Kersten JR, Pagel PS, Hettrick DA, Warltier DC. Dexmedetomidine partially attenuates the sympathetically mediated systemic and coronary hemodynamic effects of cocaine. Anesth Analg 1995;80:114-21.
18. Baddigam K, Russo P, Russo J, Tobias JD. Dexmedetomidine in the treatment of withdrawal syndrome in cardiothoracic surgery patients. J Intensive Care Med 2005;20:118-23. (Pubitemid 43093903)
19. Virtanen R, Savola JM, Saano V, Nyman L. Characterization of the selectivity, specificity and potency of medetomedine as an alpha 2-adrenoreceptor agonist. Eur J Pharmacol 1988;150:9-14.
20. Rovasalo A, Tohmo H, Aantaa R, Kettunen E, Palojoki R. Dexmedetomidine as an adjuvant in the treatment of alcohol withdrawal delirium: A case report. Gen Hosp Psychiatry 2006;28:362-3. (Pubitemid 43929129)
21. Darrouj J, Puri N, Prince E, Lomonaco A, Spevetz A, Gerber DR. Dexmedetomidine infusion as adjunctive therapy to benzodiazepines for acute alcohol withdrawal. Ann Pharmacother 2008;42:1703-5.
22. Kontak AC, Wang Z, Arbique D, Victor RG. Central sympatholysis with dexmedetomidine is an effective countermeasure for cocaine-induced sympathetic activation and peripheral vasoconstriction in chronic cocaine abusers. Circulation 2009;120:S1178.
23. Coupar IM. Effect of alpha-2 adrenoceptor agonists on the expression of morphine withdrawal in rats. Naunyn Schmiedebergs Arch Pharmacol 1992;345:553-7.
24. Lidbrink P. The effect of lesions of ascending noradrenaline pathways on sleep and waking in the rat. Brain Res 1974;74:19-40.
25. Glass MJ, Pickel VM. Alpha(2A)-adrenergic receptors are present in muopioid receptor containing neurons in rat medial nucleus tractus solitarius. Synapse 2002;43:208-18. (Pubitemid 34087676)
26. Maze M, Virtanen R, Daunt D, Banks SJ, Stover EP, Feldman D. Effects of dexmedetomidine, a novel imidazole sedative-anesthetic agent, on adrenal steroidogenesis: In vivo and in vitro studies. Anesth Analg 1991;73:204-8.
27. Meert TF, De Kock M. Potentiation of the analgesic properties of fentanyllike opioids with alpha 2-adrenoceptor agonists in rats. Anesthesiology 1994;81:677-88. (Pubitemid 24320678)